{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T06:32:45Z","timestamp":1722148365932},"reference-count":14,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T00:00:00Z","timestamp":1311292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:p>ABO\u2010mismatched plasma and platelet (PLT) transfusion have been associated with worse outcomes, including haemolysis and other reactions, compared to recipients of ABO\u2010identical products. The immune complexes that form in a mismatched transfusion have been demonstrated to stimulate pyrogenic cytokine release <jats:italic>in vitro<\/jats:italic>. Comparing ABO identical vs. ABO mismatched PLT transfusions, we found no significant difference in the ABO compatibilities between the PLT doses implicated in causing febrile non\u2010haemolytic transfusion reactions (FNHTR) in 162 recipients and both the baseline PLT donor\/recipient ABO compatibility (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b767) or the PLTs issued in the 30\u2003days preceding the FNHTR (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b792). ABO\u2010mismatched PLT transfusions do not appear to be aetiological agents of FNHTR in a population routinely receiving both ABO\u2010identical and ABO\u2010mismatched transfusions.<\/jats:p>","DOI":"10.1111\/j.1423-0410.2011.01529.x","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T01:56:26Z","timestamp":1311386186000},"page":"175-177","source":"Crossref","is-referenced-by-count":8,"title":["ABO\u2010mismatched transfusions are not over\u2010represented in febrile non\u2010haemolytic transfusion reactions to platelets"],"prefix":"10.1111","volume":"102","author":[{"given":"M. H.","family":"Yazer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"Raval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Triulzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Blumberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,7,22]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830450219"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41060790.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2010.01464.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2009.01167.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2010.175"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb03349.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(85)90054-1"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830260618"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.4049\/jimmunol.144.4.1304","article-title":"Cross\u2010linking of both Fc gamma RI and Fc gamma RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc\u2010Fc gamma R interactions. Functional activation of Fc gamma RII by treatment with proteases or neuraminidase","volume":"144","author":"Debets JM","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.35295125733.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33393174443.x"},{"key":"e_1_2_6_13_2","first-page":"251","article-title":"Febrile transfusion reaction caused by AB0\u2010incompatible platelet transfusion","volume":"15","author":"Winter PM","year":"1988","journal-title":"Infusionstherapie"},{"key":"e_1_2_6_14_2","first-page":"82A","article-title":"Providing ABO identical platelets to all patients\u2010methods and clinical outcomes","volume":"48","author":"Gettings K","year":"2008","journal-title":"Transfusion"},{"key":"e_1_2_6_15_2","volume-title":"Technical Manual","author":"Brecher ME","year":"2008"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1423-0410.2011.01529.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1423-0410.2011.01529.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T02:36:19Z","timestamp":1698633379000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1423-0410.2011.01529.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,22]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1111\/j.1423-0410.2011.01529.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1423-0410.2011.01529.x","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,22]]}}}